Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Dr Uazman Alam
BSc, MBChB, MPHe, FRCP(UK)(London), PhD

About

I obtained my BSc in Medical Science from the University of St Andrews before completing my MBChB at the University of Manchester in 2005. During my medical training (2003-2004), I also undertook an MSc in Population Health (MPHe), conducting evidence-based reviews on treatments for painful diabetic neuropathy, work that sparked my longstanding interest in diabetes complications and neuropathic pain. My early research experience began as a fourth-year medical student, studying peripheral nerve histology in experimental models of diabetic neuropathy.

Before entering higher specialist training in Endocrinology and Diabetes, I completed a PhD at the University of Manchester (2014) investigating diabetic neuropathy and vitamin D. During this period, I contributed to major NIH- and JDRF-funded projects focused on identifying novel surrogate markers of small-fibre neuropathy, with findings published in leading journals including Diabetes and Diabetes Care.

In April 2017, I was appointed Senior Clinical Lecturer and Honorary Consultant Physician in Endocrinology and Diabetes at the University of Liverpool. I am a member of the Royal College of Physicians, NeuroDiab, and Diabetes UK; a Council Member for the Lipids, Metabolism and Vascular Risk Section of the Royal Society of Medicine; Associate Editor for Clinical Medicine (RCP Journal); Topic Editor for Clinical Therapeutics; and a regular peer reviewer for leading journals including NEJM, Diabetes Care, Obesity & Metabolism, and Diabetic Medicine.

My clinical and research expertise centre on the pathogenesis, assessment, and treatment of diabetic neuropathy, and I have authored over 190 PubMed-indexed publications. I regularly present my work at national and international meetings. My work at the University of Liverpool continues to focus on diabetes complications, pain syndromes, with an expanding interest in cardiovascular disease in diabetes and obesity. More recently, I have collaborated with computer scientists for the development of Artificial Intelligence-based systems for the detection of these conditions.